Home > Insider Trading > Filing (0001140361-10-026302)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
812796	Soligenix Inc.	SNGX	Pharmaceutical Preparations (2834)	411505029

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1092601	Spa Finanziaria Tau Sigma	Via Sudafrica, 20 Rome L6 00144	No	No	Yes	No
1170881	Sa International Tau Sigma	19-21 Boulevard Du Prince Henri L-1724 N4 00000	No	No	Yes	No
1385625	Sigma-Tau Pharmaceuticals, Inc.	9841 Washingtonian Blvd. Suite 500 Gaithersburg MD 20878	No	No	Yes	No
1385930	S.a. America Sigma-Tau	19-21 Boulvard Du Prince Henri L-1724 N4 00000	No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2010-06-18	8,608,580	$0.21	54,227,816	No	4	P	Indirect	Indirect

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	Indirect

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Common Stock Warrant (right to buy)	Acquisiton	2010-06-18	1	$0.00	5,165,148	$0.28

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
1	2010-06-18	2015-06-18	No	4	J	Indirect

Footnotes

Shares directly owned by Sigma-Tau Pharmaceuticals, Inc. ("Pharmaceuticals"). Pharmaceuticals is a direct wholly-owned subsidiary of Sigma-Tau America S.A. ("America"). America is a direct wholly-owned subsidiary of Sigma-Tau International S.A. ("International"). International is a direct wholly-owned subsidiary of Sigma-Tau Finanziaria S.p.A.
This warrant was issued by the Issuer to Pharmaceuticals in consideration of Pharmaceuticals' purchase of 8,608,580 shares of common stock on June 18, 2010.
The expiration date of the warrant may be accelerated at the Issuer's option if the Issuers's common stock meets certain price thresholds and the common shares underlying the warrant are registered for resale pursuant to an effective registration statement or are freely transferable without volume restrictions pursuant to Rule 144 under the Securities Act of 1933, as amended.